Abstract | BACKGROUND: Some studies previously demonstrated that interleukin-17 (IL-17) involves in pulmonary diseases progression. Nevertheless, the role of IL-17 in community-acquired pneumonia (CAP) remains unknown. This study aims to examine the correlations between serum IL-17 with the severity and prognosis in CAP patients through a prospective cohort study. METHODS: All 239 CAP patients were recruited. Serum IL-17 was detected by enzyme-linked immunosorbent assay (ELISA). The CAP severity was evaluated through CAP severity scores, including CURB-65, CRB-65, PSI, SMART-COP, CURXO and APACHE II. RESULTS: Serum IL-17 was gradually increased consistent with the severity of CAP. Correlative analysis suggested that serum IL-17 was associated with clinical physiologic indicators among CAP patients. Logistic regression indicated that serum IL-17 was positively related to CAP severity scores. Additionally, the prognostic outcomes were tracked among CAP patients. The levels of IL-17 on admission were significantly increased in CAP patients with ICU admission, mechanical ventilation, vasoactive agent, death and longer hospitalization days. Logistic regression analyses revealed serum higher IL-17 on admission elevated the risks of vasoactive agent usage and longer hospital stays in CAP patients. The cut-off concentrations of serum IL-17 for death, ICU admission, mechanical ventilation and ≥ 14 hospital stays were 86.80 ng/mL, 84.92 ng/mL, 84.92 ng/mL and 60.29 ng/mL respectively. CONCLUSIONS: Serum IL-17 on admission is positively associated with the severity and poor prognosis among CAP patients, revealing that IL-17 may implicate in the pathological process of CAP. Therefore, serum IL-17 may become an effective biomarker for diagnosis, prognosis and therapy for CAP patients.
|
Authors | Chun-Mei Feng, Xin-Ming Wang, Meng-Die Li, Zheng Xu, Dong-Xu Hua, Jia-Yi Cheng, Ling Zheng, Hui Zhao, Lin Fu |
Journal | BMC pulmonary medicine
(BMC Pulm Med)
Vol. 21
Issue 1
Pg. 393
(Dec 02 2021)
ISSN: 1471-2466 [Electronic] England |
PMID | 34856971
(Publication Type: Journal Article)
|
Copyright | © 2021. The Author(s). |
Chemical References |
|
Topics |
- Aged
- Cohort Studies
- Community-Acquired Infections
(blood)
- Female
- Humans
- Interleukin-17
(blood)
- Male
- Middle Aged
- Pneumonia
(blood)
- Prognosis
- Prospective Studies
- Severity of Illness Index
|